Search Results - arie+belldegrun

1 Results Sort By:
New Fusion Molecule Based on Novel TAA Variant (UCLA Case No. 2007-217)
BACKGROUND: Renal cell carcinoma (RCC) affects approximately 39,000 Americans and causes an estimated 13,000 deaths per year. Metastatic RCC poses a therapeutic challenge because of its resistance to conventional modes of therapy. Approximately one third of RCC patients will present at the metastatic stage and one third of patients with localized disease...
Published: 2/16/2024   |   Inventor(s): Arie Belldegrun, Zhenhua Li
Keywords(s): Cancer, Immunotherapy, Renal, Renal cell carcinoma, renal diseases
Category(s): Therapeutics > Immunology And Immunotherapy, Therapeutics > Oncology > Oncology Immunotherapy, Therapeutics > Oncology, Therapeutics > Renal